Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab.

@article{Snyder2016VeryLR,
  title={Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab.},
  author={Laura L. Snyder and Jos{\'e} M. Garc{\'i}a-Gonz{\'a}lez and Michael J. Shapiro and Michael P. Blair},
  journal={Ophthalmic surgery, lasers & imaging retina},
  year={2016},
  volume={47 3},
  pages={
          280-3
        }
}
The authors report a case of very late reactivation of retinopathy of prematurity (ROP) after bevacizumab monotherapy. A female born at 630 g and 24 weeks received two bilateral treatment of bevacizumab (Avastin; Genentech, South San Francisco, CA) for aggressive posterior ROP (APROP). At 2.5 years of age, ROP reactivated in the form of tractional retinal… CONTINUE READING